Table 5: Importance of eligibility criteria to the principal investigators (n = 16) at each study centre when determining eligibility for of a patient for HCV treatment.
| Eligibility criteria | Median* | Range |
|---|---|---|
| Age | 1.0 | 1.0–3.0 |
| Sex | 1.0 | 1.0–3.0 |
| HCV genotype | 3.5 | 1.0–5.0 |
| Severity of fibrosis | 5.0 | 3.0–5.0 |
| Past psychiatric comorbidity | 3.0 | 1.0–5.0 |
| Current psychiatric comorbidity | 4.0 | 1.0–5.0 |
| Current incarceration | 3.0 | 1.0–5.0 |
| Past incarceration | 1.0 | 1.0–3.0 |
| Past injection drug use | 1.0 | 1.0–3.0 |
| Current injection drug use | 3.5 | 1.0–5.0 |
| Past alcohol intake | 1.0 | 1.0–4.0 |
| Current alcohol intake | 4.0 | 3.0–5.0 |
| Past HCV treatment | 4.0 | 1.0–5.0 |
| History of reinfection with HCV | 4.0 | 1.0–5.0 |
| Potential for reinfection with HCV | 3.0 | 1.0–5.0 |
HCV = hepatitis C virus *Scores were ranked from 1 to 5, with 1 being less important and 5 being very important.